{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:46:16Z","timestamp":1776440776008,"version":"3.51.2"},"reference-count":88,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.beha.2024.101576","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:47:25Z","timestamp":1724827645000},"page":"101576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Relevance of donor-specific HLA antibodies in hematopoietic cell transplantation"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-5989","authenticated-orcid":false,"given":"Thuong Hien","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Heinold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Spackova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lien","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Stelljes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dreger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.beha.2024.101576_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.humimm.2022.08.007","article-title":"Current donor selection strategies for allogeneic hematopoietic cell transplantation","volume":"83","author":"Timofeeva","year":"2022","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.beha.2024.101576_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/hematology.2019000057","article-title":"Selection of matched unrelated donors moving forward: from HLA allele counting to functional matching","volume":"2019","author":"Fleischhauer","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"15","key":"10.1016\/j.beha.2024.101576_bib3","first-page":"261","article-title":"Donor selection for allogeneic hematopoietic cell transplantation","volume":"120","author":"Fleischhauer","year":"2023","journal-title":"Dtsch Arztebl Int"},{"issue":"8","key":"10.1016\/j.beha.2024.101576_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3181b9d710","article-title":"High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation","volume":"88","author":"Ciurea","year":"2009","journal-title":"Transplantation"},{"issue":"13","key":"10.1016\/j.beha.2024.101576_bib5","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2009-09-244525","article-title":"The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure","volume":"115","author":"Spellman","year":"2010","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.beha.2024.101576_bib6","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","article-title":"The impact of anti-HLA antibodies on unrelated cord blood transplantations","volume":"116","author":"Takanashi","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2024.101576_bib7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3324\/haematol.2012.077685","volume":"98","author":"Ruggeri","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2024.101576_bib8","article-title":"Posttransplant de novo DSA and NDSA affect GvHD, OS, and DFS after haploidenticalHCT in patients without pre-existing HLA antibodies of hematological malignancies","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.beha.2024.101576_bib9","article-title":"The impact of pre-transplant anti-HLA antibodies in transplants from HLA-identical sibling donors: a multicenter study","author":"Wei","year":"2023","journal-title":"Hla"},{"issue":"8","key":"10.1016\/j.beha.2024.101576_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.humimm.2020.05.006","article-title":"Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients","volume":"81","author":"Andolina","year":"2020","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib11","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.1002\/ajh.25762","article-title":"Donor-specific anti-HLA antibodies and \u2026recipient-specific anti-HLA antibodies? The conundrum on pregnancy in transplantation","volume":"95","author":"Ciurea","year":"2020","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.beha.2024.101576_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system. First of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.beha.2024.101576_bib13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM200009143431106","article-title":"The HLA system. Second of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.beha.2024.101576_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-0039.2009.01291.x","article-title":"A short history of HLA","volume":"74","author":"Thorsby","year":"2009","journal-title":"Tissue Antigens"},{"issue":"12","key":"10.1016\/j.beha.2024.101576_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.beha.2024.101576_bib16","first-page":"261","article-title":"Donor selection for allogeneic hematopoietic cell transplantation","volume":"120","author":"Fleischhauer","year":"2023","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"10.1016\/j.beha.2024.101576_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1034\/j.1600-6143.2003.00135.x","article-title":"Humoral theory of transplantation","volume":"3","author":"Terasaki","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.beha.2024.101576_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bmb\/lds037","article-title":"Humoral theory of transplantation: some hot topics","volume":"105","author":"Cai","year":"2013","journal-title":"Br Med Bull"},{"issue":"8","key":"10.1016\/j.beha.2024.101576_bib19","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/00007890-200204270-00016","article-title":"Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation","volume":"73","author":"Ottinger","year":"2002","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.beha.2024.101576_bib20","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.bbmt.2015.05.001","article-title":"Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation","volume":"21","author":"Ciurea","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"10.1016\/j.beha.2024.101576_bib21","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1182\/blood-2011-06-362111","article-title":"Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation","volume":"118","author":"Ciurea","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","article-title":"The European society for blood and marrow transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation","volume":"53","author":"Ciurea","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2024.101576_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.humimm.2015.07.192","article-title":"Are IgM donor-specific hla antibodies (DSA) clinically relevant?","volume":"76","author":"Warner","year":"2015","journal-title":"Hum Immunol"},{"key":"10.1016\/j.beha.2024.101576_bib24","first-page":"173","article-title":"Clinical relevance of donor-specific IgM antibodies in HLA incompatible renal transplantation: a retrospective single-center study","volume":"32","author":"Babu","year":"2016","journal-title":"Clin Transpl"},{"issue":"6176","key":"10.1016\/j.beha.2024.101576_bib25","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1399-0039.2012.01954.x","article-title":"Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry","volume":"80","author":"AlMahri","year":"2012","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib27","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4049\/jimmunol.180.4.2357","article-title":"HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway","volume":"180","author":"Jindra","year":"2008","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.beha.2024.101576_bib28","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.1201434","article-title":"HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging Fc\u03b3Rs","volume":"190","author":"Valenzuela","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s40472-016-0116-7","article-title":"Fc\u03b3 receptors in solid organ transplantation","volume":"3","author":"Castro-Dopico","year":"2016","journal-title":"Curr Transplant Rep"},{"issue":"3","key":"10.1016\/j.beha.2024.101576_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.imlet.2004.01.012","article-title":"Fc gamma receptors","volume":"92","author":"Cohen-Solal","year":"2004","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/icb.2017.6","article-title":"Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells","volume":"95","author":"Ochoa","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.beha.2024.101576_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10465","article-title":"The role of Fc gamma receptors in antibody-mediated rejection of kidney transplants","volume":"35","author":"Delpire","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.beha.2024.101576_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fimmu.2016.00307","article-title":"Donor-specific anti-HLA antibodies in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Morin-Zorman","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.beha.2024.101576_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/asheducation-2017.1.645","article-title":"HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities","volume":"2017","author":"Gladstone","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib35","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/TP.0b013e31829c2481","article-title":"On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI","volume":"96","author":"Friedlander","year":"2013","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/tan.15082","article-title":"A modeling approach for mean fluorescence intensity value harmonization and cutoff prediction for luminex single antigen bead assays of two different vendors","volume":"102","author":"Karahan","year":"2023","journal-title":"HLA"},{"issue":"9","key":"10.1016\/j.beha.2024.101576_bib37","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.beha.2024.101576_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jim.2017.07.016","article-title":"Monitoring native HLA-I trimer specific antibodies in Luminex multiplex single antigen bead assay: evaluation of beadsets from different manufacturers","volume":"450","author":"Ravindranath","year":"2017","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.beha.2024.101576_bib39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cei.12127","article-title":"The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation","volume":"173","author":"Otten","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.beha.2024.101576_bib40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0000000000000229","article-title":"Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation","volume":"98","author":"Visentin","year":"2014","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ctr.12529","article-title":"Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation","volume":"29","author":"Visentin","year":"2015","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.beha.2024.101576_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/tan.13038","article-title":"Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation","volume":"90","author":"Kramer","year":"2017","journal-title":"Hla"},{"issue":"1","key":"10.1016\/j.beha.2024.101576_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/tri.13362","article-title":"The long and winding road towards epitope matching in clinical transplantation","volume":"32","author":"Kramer","year":"2019","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.beha.2024.101576_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humimm.2018.11.007","article-title":"Second update of the international registry of HLA epitopes. I. The HLA-ABC epitope Database","volume":"80","author":"Duquesnoy","year":"2019","journal-title":"Hum Immunol"},{"issue":"7","key":"10.1016\/j.beha.2024.101576_bib45","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.beha.2024.101576_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10511","article-title":"European guideline for the management of kidney transplant patients with HLA antibodies: by the European society for organ transplantation working group","volume":"35","author":"Mamode","year":"2022","journal-title":"Transpl Int"},{"issue":"6","key":"10.1016\/j.beha.2024.101576_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/tan.14790","article-title":"Cumulative mean fluorescent intensities of HLA specific antibodies predict antibody mediated rejections after kidney transplantation","volume":"100","author":"Heinemann","year":"2022","journal-title":"HLA"},{"issue":"1","key":"10.1016\/j.beha.2024.101576_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tan.14521","article-title":"Determination of unacceptable HLA antigen mismatches in kidney transplant recipients","volume":"100","author":"Ziemann","year":"2022","journal-title":"Hla"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/tan.12682","article-title":"Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics","volume":"86","author":"S\u00fcsal","year":"2015","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.beha.2024.101576_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2024.101576_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101566","article-title":"Effect of C1q-binding donor-specific anti-HLA antibodies on the clinical outcomes of patients after renal transplantation: a systematic review and meta-analysis","volume":"72","author":"Kang","year":"2022","journal-title":"Transpl Immunol"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib52","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MOT.0000000000000659","article-title":"A diagnostic 'C' saw: the ups and downs of C1q testing","volume":"24","author":"Gebel","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"10.1016\/j.beha.2024.101576_bib53","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ajt.14015","article-title":"Evaluation of C1q status and titer of de novo donor-specific antibodies as predictors of allograft survival","volume":"17","author":"Wiebe","year":"2017","journal-title":"Am J Transplant"},{"issue":"14","key":"10.1016\/j.beha.2024.101576_bib54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beha.2024.101576_bib55","first-page":"1759","article-title":"Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation","volume":"53","author":"Lesley","year":"1974","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib56","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/tan.12537","article-title":"Inter-individual differences in HLA expression can impact the CDC crossmatch","volume":"85","author":"Honger","year":"2015","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.beha.2024.101576_bib57","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.humimm.2015.09.029","article-title":"Variable HLA expression on deceased donor lymphocytes: not all crossmatches are created equal","volume":"76","author":"Badders","year":"2015","journal-title":"Hum Immunol"},{"issue":"8","key":"10.1016\/j.beha.2024.101576_bib58","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.1403234","article-title":"Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells","volume":"194","author":"Apps","year":"2015","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib59","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.4049\/jimmunol.139.4.1336","article-title":"Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell types","volume":"139","author":"Berdoz","year":"1987","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/iji.12443","article-title":"Factors affecting HLA expression: a review","volume":"46","author":"Carey","year":"2019","journal-title":"Int J Immunogenet"},{"issue":"10","key":"10.1016\/j.beha.2024.101576_bib61","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib62","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41409-019-0712-0","article-title":"Impact of pretransplant donor-specific anti-HLA antibodies on cord blood transplantation on behalf of the transplant complications working group of Japan society for hematopoietic cell transplantation","volume":"55","author":"Fuji","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"25","key":"10.1016\/j.beha.2024.101576_bib63","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1182\/blood-2011-05-355263","article-title":"Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation","volume":"118","author":"Cutler","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib64","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bmt.2011.131","article-title":"Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT","volume":"47","author":"Yoshihara","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2024.101576_bib65","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-015-0182-9","article-title":"Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets","volume":"8","author":"Chang","year":"2015","journal-title":"J Hematol Oncol"},{"issue":"20","key":"10.1016\/j.beha.2024.101576_bib66","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/bloodadvances.2021004862","article-title":"Treatment of allosensitized patients receiving allogeneic transplantation","volume":"5","author":"Ciurea","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/TP.0000000000000203","article-title":"Determinants of C1q binding in the single antigen bead assay","volume":"98","author":"Schaub","year":"2014","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.beha.2024.101576_bib68","doi-asserted-by":"crossref","first-page":"687 e1","DOI":"10.1016\/j.jtct.2021.04.030","article-title":"Donor-specific antibodies and primary graft failure in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"27","author":"Xie","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.beha.2024.101576_bib69","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.bbmt.2019.02.020","article-title":"Donor-specific anti-HLA antibodies in haploidentical stem cell transplantation with post-transplantation cyclophosphamide: risk of graft failure, poor graft function, and impact on outcomes","volume":"25","author":"Bramanti","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.beha.2024.101576_bib70","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41409-018-0334-y","article-title":"Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders","volume":"54","author":"Woolfrey","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.beha.2024.101576_bib71","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.bbmt.2011.04.013","article-title":"Anti-HLA antibodies in double umbilical cord blood transplantation","volume":"17","author":"Brunstein","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.beha.2024.101576_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/tan.14817","article-title":"Presence of antibodies against HLA class I and class II molecules in children before and after allo-HCT. Alloantibodies before and after HCT","volume":"101","author":"Mor\u00e1n-Espinosa","year":"2023","journal-title":"Hla"},{"key":"10.1016\/j.beha.2024.101576_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110299","article-title":"High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant","volume":"120","author":"Zhu","year":"2023","journal-title":"Int Immunopharm"},{"issue":"6","key":"10.1016\/j.beha.2024.101576_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14972","article-title":"Infection-related mortality after HLA-identical and haploidentical hematopoietic cell transplantation using reduced-intensity conditioning in an outpatient setting","volume":"37","author":"Jaime-P\u00e9rez","year":"2023","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.beha.2024.101576_bib75","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41409-020-0928-z","article-title":"Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody","volume":"55","author":"Chang","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib76","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41409-022-01578-w","article-title":"The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies","volume":"57","author":"File","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib77","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/bmt.2014.11","article-title":"A strategy to reduce donor-specific HLA Abs before allogeneic transplantation","volume":"49","author":"Gergis","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.beha.2024.101576_bib78","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/bmt.2014.331","article-title":"Donor HLA-specific Abs: to BMT or not to BMT?","volume":"50","author":"Leffell","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2024.101576_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674658","article-title":"Management of donor-specific antibodies in haploidentical transplant: multicenter experience from the Madrid group of hematopoietic transplant","volume":"12","author":"Bail\u00e9n","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.beha.2024.101576_bib80","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trre.2013.07.001","article-title":"Interpretation of HLA single antigen bead assays","volume":"27","author":"Ellis","year":"2013","journal-title":"Transplant Rev"},{"issue":"7\u20138","key":"10.1016\/j.beha.2024.101576_bib81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.humimm.2017.05.007","article-title":"Understanding solid-phase HLA antibody assays and the value of MFI","volume":"78","author":"Sullivan","year":"2017","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib82","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/ajt.13192","article-title":"HLA epitopes as viewed by antibodies: what is it all about?","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.beha.2024.101576_bib83","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.humimm.2022.01.001","article-title":"Autobiographical perspectives on HLA epitopes: past, present and future","volume":"83","author":"Duquesnoy","year":"2022","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.beha.2024.101576_bib84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.humimm.2021.12.002","article-title":"Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes","volume":"83","author":"Bezstarosti","year":"2022","journal-title":"Hum Immunol"},{"key":"10.1016\/j.beha.2024.101576_bib85","article-title":"A comprehensive evaluation of the antibody-verified status of eplets listed in the HLA epitope registry","volume":"12","author":"Bezstarosti","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.beha.2024.101576_bib86","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/iji.12552","article-title":"Approaches for the characterization of clinically relevant pre-transplant human leucocyte antigen (HLA) antibodies in solid organ transplant patients","volume":"48","author":"Rosser","year":"2021","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.beha.2024.101576_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.916200","article-title":"Donor specific HLA antibody in hematopoietic stem cell transplantation: implications for donor selection","volume":"13","author":"Krummey","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.beha.2024.101576_bib88","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/bmt.2017.7","article-title":"Untreated donor specific antibodies against HLA are associated with poor outcomes in peripheral blood haploidentical hematopoietic cell transplantation","volume":"52","author":"Zou","year":"2017","journal-title":"Bone Marrow Transplant"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692624000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692624000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T20:01:24Z","timestamp":1728590484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692624000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1521692624000422"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2024.101576","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relevance of donor-specific HLA antibodies in hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2024.101576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101576"}}